System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Laurent Poulain is an expert in Oncology at Centre François Baclesse (France). Laurent Poulain has authored 123 publications, the most recent in 2026. SLR score: 625 (community average: 125). How the SLR is computed.

LeadR Profile

Laurent Poulain Centre François Baclesse France
625 ScienceLeadR Reputation 625

Unlock

Register Login
Network Map

Oncology

Subspecialties: Biochemistry - Gynecology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026
Source: PubMed

Centre François Baclesse

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 123

Citations

Citations: 3 510 1st author: 4 Last author: 31 Unique author: 0

Main journals

BMC Cancer 7
Cancer Res 7
Gynecol Oncol 5
Int J Cancer 5
Anticancer Res 4

Best Journals

Lancet Haematol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Targeting Both Oncogenic Signaling and Dependence Receptor Function is Required to Fully Suppress MET Exon 14 Skipping-Driven tumorigenesis.
PMID 42709847 — neoplasms, caspases, exons, carcinogenesis, apoptosis, ligands, mutation		Cancer Res20260
Establishment of a clear cell renal cell carcinoma organoid cohort integrated into the UroCCR clinical database: A feasibility study.
PMID 42372405 — cells, feasibility studies, neoplasms, carcinoma, renal cell, organoids, therapeutics		Transl Oncol20260
When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic Composition.
PMID 42236828 — cells, neoplasms, therapeutics		NPJ Precis Oncol20260
UPR/ATF4/Noxa pathway overactivation through SERCA2 inhibition or ONC201 treatment combined with ABT-737 triggers apoptosis in chemoresistant ovarian cancer cells and patient-derived tumor organoids.
PMID 41896216 — cells, stress, physiological, ovary, neoplasms, organoids, ovarian neoplasms, calcium, therapeutics, apoptosis, cell death		Cell Death Dis20260
Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response.
PMID 41057919 — pharmaceutical preparations, ovary, neoplasms, drug therapy, organoids, ovarian neoplasms, genomic instability, medical oncology, chemotherapy		J Exp Clin Cancer Res20256

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS